Analysis | Metabolite Name | Measured Value | Units | AGE | Assay | DISEASE_STATE | Timepoint |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4072 | Peak area normalized | 14 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4286 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4287 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4388 | Peak area normalized | 15 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4389 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4476 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4484 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4589 | Peak area normalized | 15 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4750 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4853 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4889 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4905 | Peak area normalized | 13 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4931 | Peak area normalized | 13 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 4988 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5108 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5168 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5433 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5440 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5516 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5584 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5589 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5594 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5640 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5687 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5791 | Peak area normalized | 17 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5870 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5887 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 5943 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6028 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6147 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6212 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6301 | Peak area normalized | 14 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6303 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6316 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6405 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6441 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6572 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6619 | Peak area normalized | 13 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6632 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6688 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6742 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6789 | Peak area normalized | 17 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6792 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6819 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6820 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6900 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6954 | Peak area normalized | 13 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 6967 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7150 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7177 | Peak area normalized | 14 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7265 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7365 | Peak area normalized | 15 | OGTT | PCOS | 90 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7421 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7529 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7550 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7711 | Peak area normalized | 17 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7739 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7744 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7827 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 7931 | Peak area normalized | 14 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8067 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8139 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8234 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8290 | Peak area normalized | 14 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8410 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8503 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8527 | Peak area normalized | 17 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 8739 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 9038 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 9109 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 9111 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 9128 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 9185 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 9884 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 10195 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 10299 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 11060 | Peak area normalized | 14 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | 12655 | Peak area normalized | 15 | OGTT | PCOS | 30 |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 12 | OGTT | Control | - | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 12 | OGTT | Control | 120 | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 12 | OGTT | PCOS | - | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 12 | OGTT | PCOS | 120 | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 13 | BC TP | Control | - | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 13 | BC TP | Control | 270 | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 15 | OGTT | PCOS | - | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 15 | OGTT | PCOS | 120 | |
Reversed phase NEGATIVE ION MODE | LYSINE (M-H)- | Peak area normalized | 16 | OGTT | PCOS | 120 | |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 16023 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 20607 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 20888 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 21920 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 22014 | Peak area normalized | 15 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 22031 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 22534 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 22911 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 23298 | Peak area normalized | 17 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 23538 | Peak area normalized | 13 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 23598 | Peak area normalized | 14 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 24537 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 24605 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 25273 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 25803 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 26364 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 26421 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 26579 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 26640 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 26933 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 27100 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 27549 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 27609 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 27629 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 27963 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 28156 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 28268 | Peak area normalized | 14 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 28357 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 29227 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 29521 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 29538 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 29577 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 29768 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 29898 | Peak area normalized | 13 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 30631 | Peak area normalized | 15 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 30879 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 31227 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 31860 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 32441 | Peak area normalized | 13 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 32583 | Peak area normalized | 17 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 32837 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 33060 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 33239 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 33443 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 33604 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 33619 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 33636 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34041 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34133 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34256 | Peak area normalized | 14 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34282 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34452 | Peak area normalized | 15 | OGTT | PCOS | 90 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34683 | Peak area normalized | 13 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34710 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34820 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34903 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 34995 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 35007 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 35326 | Peak area normalized | 17 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 35358 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 35955 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 36036 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 36091 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 36365 | Peak area normalized | 14 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 36536 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 36658 | Peak area normalized | 14 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 37169 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 37386 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 37432 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 37484 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 38066 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 38708 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 39092 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 39204 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 39233 | Peak area normalized | 17 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 39921 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 40365 | Peak area normalized | 15 | OGTT | PCOS | 30 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 40452 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 41842 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 42607 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 42986 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 43115 | Peak area normalized | 14 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 43254 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 59944 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 61286 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 66309 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 73181 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 80297 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 88706 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 3292 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 3908 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 4488 | Peak area normalized | 15 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5072 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5137 | Peak area normalized | 17 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5230 | Peak area normalized | 14 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5261 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5265 | Peak area normalized | 13 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5276 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5657 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5749 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5817 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5878 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5884 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 5917 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6008 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6053 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6063 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6177 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6210 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6211 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6228 | Peak area normalized | 15 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6388 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 6427 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Return to search page